U赢电竞

KEY PRODUCTS
KEY PRODUCTS CTTQ manufactures over 50 prescription medicines in 5 core therapeutic areas.
Product Current Status Specification
Amifostine USDMF: 21765 USP
Bendamustine HCl USDMF: 27018 In-House
Colistimethate Sodium CEP: 2015-189 EP / USP
Fosaprepitant Dimeglumine USDMF: 28288 In-House
Foscarnet Sodium USDMF: 29056 EP / USP
Fulvestrant DMF under preparation In-House
Products under evaluation
Degarelix Acetate
Everolimus
Gadoteridol
Gadoxetate Disodium
Ibrutinib
The above mentioned products are not available in countries where valid patents exist.